Algorae Pharmaceuticals (ASX:1AI) Total Assets : A$3.76 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Algorae Pharmaceuticals Total Assets?

Algorae Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2023 was A$3.76 Mil.

During the past 12 months, Algorae Pharmaceuticals's average Total Assets Growth Rate was 360.00% per year. During the past 3 years, the average Total Assets Growth Rate was -38.10% per year. During the past 5 years, the average Total Assets Growth Rate was -47.00% per year. During the past 10 years, the average Total Assets Growth Rate was -37.60% per year.

During the past 13 years, Algorae Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 50.40%. The lowest was -70.40%. And the median was 7.20%.

Total Assets is connected with ROA %. Algorae Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2023 was -72.80%. Total Assets is also linked to Revenue through Asset Turnover. Algorae Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2023 was 0.00.

Algorae Pharmaceuticals Total Assets Historical Data

The historical data trend for Algorae Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algorae Pharmaceuticals Total Assets Chart

Algorae Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Assets

Get a 7-Day Free Trial

5.76

3.39

1.64

4.27

4.21

Algorae Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Assets	Get a 7-Day Free Trial															4.46	4.27	3.12	4.21	3.76

Algorae Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Algorae Pharmaceuticals's Total Assets for the fiscal year that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (A: Jun. 2023 )	+	Total Liabilities (A: Jun. 2023 )
	=	3.762	+	0.45
	=	4.21

Algorae Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	3.619	+	0.14
	=	3.76

Algorae Pharmaceuticals (ASX:1AI) Total Assets Explanation

Total Assets is connected with ROA %.

Algorae Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-2.902	/	( (4.212	+	3.76)	/ 2 )
	=	-2.902	/	3.986
	=	-72.80 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Algorae Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0	/	( (4.212	+	3.76)	/ 2 )
=	0	/	3.986
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Algorae Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of Algorae Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Algorae Pharmaceuticals (ASX:1AI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algorae Pharmaceuticals Ltd (ASX:1AI) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

LVCLY:USA LVCLF:USA LHI0:Germany

Address

201 Sussex Street, Level 16, Tower 2, Darling Park, Sydney, NSW, AUS, 2000

Website

https://www.algoraepharma.com

Algorae Pharmaceuticals Ltd is a clinical-stage pharmaceutical company developing transformative solutions for undermet medical needs in the community. The firm develops AlgoraeOS, a closed-loop platform, leveraging computational tools to generate novel insights in silico that are being developed to initiate or accelerate therapeutic programs. Its lead products comprise AI-116, a novel combination drug candidate of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. It is conceptualised to be a potential treatment for dementia, including Alzheimer's disease; NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. It also offers LP-003 Anti-obesity Drug and LC-002 migraine treatment.

Algorae Pharmaceuticals (ASX:1AI) Headlines

No Headlines